Factor Xa inhibitor vs. aspirin in extended phase of prevention recurrent VTE
This video was recorded during ACC 2017, March 17-19 in Washington, DC, USA. PACE-cme did not receive financial support for the production of this video.
The educational content reflects the personal opinion of the expert.
Dr. Philip Wells - University of Ottawa, ONT, Canada